Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 3717
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Losartan-induced ischemic hepatocellular hepatotoxicity: A case report and literature review

Al-Halawani Moh«SQ»d Z, Thawabi Mohammad, Asslo Fady, Shaaban Hamid, Shamoon Fayez, Baddoura Walid J

Year : 2014| Volume: 3| Issue : 3 | Page no: 272-274

   This article has been cited by
1 Serious Adverse Events Reported with Dietary Supplement Use in the United States: A 2.5 Year Experience
Stephen M. Schmitz,Hector L. Lopez,Douglas Mackay,Haiuyen Nguyen,Paula E. Miller
Journal of Dietary Supplements. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers
Dae Hwa Park,Gee Young Yun,Hyuk Soo Eun,Jong Seok Joo,Ju Seok Kim,Sun Hyung Kang,Hee Seok Moon,Eaum Seok Lee,Byung Seok Lee,Kyung Hee Kim,Seok Hyun Kim
Medicine. 2017; 96(47): e8905
[Pubmed]  [Google Scholar] [DOI]
3 Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor
Roberta Sessa Stilhano,Vivian Yochiko Samoto,Leonardo Martins Silva,Gustavo José Pereira,Adolfo Garcia Erustes,Soraya Soubhi Smaili,Sang Won Han,Luis Eduardo M Quintas
PLOS ONE. 2017; 12(10): e0186719
[Pubmed]  [Google Scholar] [DOI]
4 Liver disease and heart failure: Back and forth
Michele Correale,Nicola Tarantino,Rossella Petrucci,Lucia Tricarico,Irma Laonigro,Matteo Di Biase,Natale Daniele Brunetti
European Journal of Internal Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article